Suven Pharmaceuticals (BOM:543064) EBIT per Share : ₹16.25 (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Suven Pharmaceuticals EBIT per Share?

Suven Pharmaceuticals's EBIT per Share for the three months ended in Mar. 2024 was ₹2.97. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹16.25.

During the past 12 months, the average EBIT per Share Growth Rate of Suven Pharmaceuticals was -33.20% per year. During the past 3 years, the average EBIT per Share Growth Rate was -5.10% per year. During the past 5 years, the average EBIT per Share Growth Rate was 16.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Suven Pharmaceuticals's EBIT per Share or its related term are showing as below:

BOM:543064' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -5.1 Med: 13.3 Max: 49.3
Current: -5.1

During the past 6 years, the highest 3-Year average EBIT per Share Growth Rate of Suven Pharmaceuticals was 49.30% per year. The lowest was -5.10% per year. And the median was 13.30% per year.

BOM:543064's 3-Year EBIT Growth Rate is ranked worse than
70.22% of 863 companies
in the Drug Manufacturers industry
Industry Median: 7.3 vs BOM:543064: -5.10

Suven Pharmaceuticals's EBIT for the three months ended in Mar. 2024 was ₹754 Mil.

Suven Pharmaceuticals EBIT per Share Historical Data

The historical data trend for Suven Pharmaceuticals's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suven Pharmaceuticals EBIT per Share Chart

Suven Pharmaceuticals Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EBIT per Share

Get a 7-Day Free Trial

16.67

18.73

26.47

22.50

16.23

Suven Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial															6.91	6.49	4.17	2.63	2.97

Suven Pharmaceuticals EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Suven Pharmaceuticals's EBIT per Share for the fiscal year that ended in Mar. 2024 is calculated as

	EBIT per Share		(A: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	4131.227	/	254.475
=	16.23

Suven Pharmaceuticals's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	753.847	/	254.269
=	2.96

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹16.25

Suven Pharmaceuticals (BOM:543064) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Suven Pharmaceuticals EBIT per Share Related Terms

Thank you for viewing the detailed overview of Suven Pharmaceuticals's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Suven Pharmaceuticals (BOM:543064) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Suven Pharmaceuticals Ltd (BOM:543064) » Definitions » EBIT per Share

Traded in Other Exchanges

SUVENPHAR:India

Address

3rd Floor, Road No. 5, Avenue 7, Banjara Hills, No. 8-2-334, SDE Serene Chambers, Hyderabad, TG, IND, 500034

Website

https://www.suvenpharm.com

Suven Pharmaceuticals Ltd is engaged in the development and manufacturing of Intermediates, Active Pharmaceutical Ingredients (API), specialty chemicals and formulated drugs under Contract Research and Manufacturing Services (CRAMS) for global pharmaceutical, biotechnology and chemical companies. The company has single operating segment that is Pharmaceuticals Manufacturing & Services and its geographical segments include India; the USA; Europe and the Rest of the World. The company derives a majority of revenue from the Europe segment.

Suven Pharmaceuticals (BOM:543064) Headlines

No Headlines